These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3311346)

  • 21. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis of ras oncogene p21 product in human gastric carcinomas and their adjacent mucosas.
    Carneiro F; David L; Sunkel C; Lopes C; Sobrinho-Simões M
    Pathol Res Pract; 1992 Apr; 188(3):263-72. PubMed ID: 1625989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical and immunoblot analyses of ras-p21 expression in lung carcinomas.
    Koshiishi Y; Noguchi M; Nakajima T; Hirohashi S; Shimosato Y; Hayata Y
    Acta Pathol Jpn; 1989 Oct; 39(10):643-7. PubMed ID: 2686349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical analysis of ras oncogene expression in epithelial neoplasms of the colon.
    Jansson DS; Radosevich JA; Carney WP; Rosen ST; Schlom J; Staren ED; Hyser MJ; Gould VE
    Cancer; 1990 Mar; 65(6):1329-37. PubMed ID: 2407334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Hashimoto T; Terahata S; Matsubara F; Michigishi T; Noguchi M
    Cancer; 1988 Mar; 61(5):873-80. PubMed ID: 3276392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies.
    Yoshida K; Hamatani K; Koide H; Abe Y; Ikeda H; Tsuchiyama H; Nakayama E; Shiku H
    Cancer Detect Prev; 1988; 12(1-6):369-76. PubMed ID: 3052835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas.
    Czerniak B; Chen R; Tuziak T; Markiewski M; Kram A; Gorczyca W; Deitch D; Herz F; Koss LG
    Cancer; 1989 May; 63(10):2008-13. PubMed ID: 2467732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of ras gene alterations and ras proteins in colorectal cancer.
    Salhab N; Jones DJ; Bos JL; Kinsella A; Schofield PF
    Dis Colon Rectum; 1989 Aug; 32(8):659-64. PubMed ID: 2666051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoprecipitation of cell lysates with RAP-5 does not specifically detect ras oncogene product p21.
    Gutheil JC; Mane S; Kapil V; Needleman SW
    Hum Pathol; 1989 Dec; 20(12):1176-80. PubMed ID: 2687155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Information value of a complex gastrological study method and its separate components in diagnosing destructive lesions of the gastric mucosa].
    Kliukina LB; Golub GD; Salomatin VI
    Vopr Onkol; 1982; 28(11):33-9. PubMed ID: 7147829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
    Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma.
    Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M
    Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of tolonium chloride in the diagnosis of malignant gastric ulcers.
    Giler S; Kadish U; Urca I
    Arch Surg; 1978 Feb; 113(2):136-9. PubMed ID: 75723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
    Johnson TL; Lloyd RV; Thor A
    Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Spandidos DA
    Anticancer Res; 1989; 9(6):1505-10. PubMed ID: 2697179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopical study of gastric mucosa: ulcerative lesion.
    Wang TH
    Taiwan Yi Xue Hui Za Zhi; 1971 Mar; 70(3):167-73. PubMed ID: 5281519
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oncogene products as tumor markers].
    Shiku H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2212-7. PubMed ID: 3300559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.
    Ghosh AK; Moore M; Harris M
    J Clin Pathol; 1986 Apr; 39(4):428-34. PubMed ID: 3009557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.